BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Treatment
9 results:

  • 1. Germline drivers of gynecologic carcinosarcomas.
    Sia TY; Gordhandas SB; Birsoy O; Kemel Y; Maio A; Salo-Mullen E; Sheehan M; Hensley ML; Rubinstein M; Makker V; Grisham RN; O'Cearbhaill RE; Roche KL; Mueller JJ; Leitao MM; Sonoda Y; Chi DS; Abu-Rustum NR; Berger MF; Ellenson LH; Latham A; Stadler Z; Offit K; Aghajanian C; Weigelt B; Mandelker D; Liu YL
    Gynecol Oncol; 2023 Jul; 174():34-41. PubMed ID: 37149903
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
    Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
    Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Expression of Programmed Cell Death-L1 (PD-L1) Protein and Mismatch Repair Mutations in Orbital Tumours-a Pilot Study.
    AlSemari MA; Strianese D; Abu Safieh L; Al Hussain H; Abedalthagafi M; Edward DP
    Eur J Ophthalmol; 2022 Sep; 32(5):3097-3102. PubMed ID: 34931541
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ewing-like sarcoma/undifferentiated round cell sarcoma in an infant with APC and msh6 variation: A case report.
    Xiong J; Zhu K; Mao J; Cai J; He M; Li L; Wang J; Wang L
    Medicine (Baltimore); 2019 Nov; 98(45):e17872. PubMed ID: 31702654
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [A Case of Laparoscopic Surgery Performed for Lynch Syndrome in a Patient Who Developed Cecal Cancer and Uterine Carcinosarcoma Synchronously].
    Murakami T; Matsumoto T; Murashima N; Nishina T; Fujimoto Y; Sugiu K; Nagasaka T
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2042-2044. PubMed ID: 30692278
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Inhibitory effect of msh6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.
    Liu HC; Zeng J; Zhang B; Liu XQ; Dai M
    J Cell Physiol; 2019 Jun; 234(6):9358-9369. PubMed ID: 30456894
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.
    Lavoine N; Colas C; Muleris M; Bodo S; Duval A; Entz-Werle N; Coulet F; Cabaret O; Andreiuolo F; Charpy C; Sebille G; Wang Q; Lejeune S; Buisine MP; Leroux D; Couillault G; Leverger G; Fricker JP; Guimbaud R; Mathieu-Dramard M; Jedraszak G; Cohen-Hagenauer O; Guerrini-Rousseau L; Bourdeaut F; Grill J; Caron O; Baert-Dusermont S; Tinat J; Bougeard G; Frébourg T; Brugières L
    J Med Genet; 2015 Nov; 52(11):770-8. PubMed ID: 26318770
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression.
    Grzankowski KS; Shimizu DM; Kimata C; Black M; Terada KY
    Gynecol Oncol; 2012 Sep; 126(3):408-12. PubMed ID: 22617524
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
    de Jong RA; Nijman HW; Wijbrandi TF; Reyners AK; Boezen HM; Hollema H
    Mod Pathol; 2011 Oct; 24(10):1368-79. PubMed ID: 21572397
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.